These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 27622369)

  • 1. Treatment of Diverticular Disease With Aminosalicylates: The Evidence.
    Barbara G; Cremon C; Barbaro MR; Bellacosa L; Stanghellini V
    J Clin Gastroenterol; 2016 Oct; 50 Suppl 1():S60-3. PubMed ID: 27622369
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of mesalazine on recurrence of diverticulitis in patients with symptomatic uncomplicated diverticular disease: a meta-analysis with trial sequential analysis of randomized controlled trials.
    Khan RMA; Ali B; Hajibandeh S; Hajibandeh S
    Colorectal Dis; 2018 Jun; 20(6):469-478. PubMed ID: 29520987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mesalazine for the Treatment of Symptomatic Uncomplicated Diverticular Disease of the Colon and for Primary Prevention of Diverticulitis: A Systematic Review of Randomized Clinical Trials.
    Picchio M; Elisei W; Brandimarte G; Di Mario F; Malfertheiner P; Scarpignato C; Tursi A
    J Clin Gastroenterol; 2016 Oct; 50 Suppl 1():S64-9. PubMed ID: 27622370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aminosalicylates.
    Gross V
    Dig Dis; 2012; 30(1):92-9. PubMed ID: 22572694
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of mesalazine in diverticular disease.
    Di Mario F; Comparato G; Fanigliulo L; Aragona G; Cavallaro LG; Cavestro GM; Franzé A
    J Clin Gastroenterol; 2006 Aug; 40 Suppl 3():S155-9. PubMed ID: 16885700
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mesalazine to treat symptomatic uncomplicated diverticular disease and to prevent acute diverticulitis occurrence. A systematic review with meta-analysis of randomized, placebo-controlled trials.
    Picchio M; Elisei W; Tursi A
    J Gastrointestin Liver Dis; 2018 Sep; 27(3):291-297. PubMed ID: 30240473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention of complications and symptomatic recurrences in diverticular disease with mesalazine: a 12-month follow-up.
    Comparato G; Fanigliulo L; Cavallaro LG; Aragona G; Cavestro GM; Iori V; Maino M; Mazzocchi G; Muzzetto P; Colla G; Sianesi M; Franzé A; Mario FD
    Dig Dis Sci; 2007 Nov; 52(11):2934-41. PubMed ID: 17410435
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathophysiology and Therapeutic Strategies for Symptomatic Uncomplicated Diverticular Disease of the Colon.
    Scaioli E; Colecchia A; Marasco G; Schiumerini R; Festi D
    Dig Dis Sci; 2016 Mar; 61(3):673-83. PubMed ID: 26458921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mesalazine for People with Diverticular Disease: A Systematic Review of Randomized Controlled Trials.
    Iannone A; Ruospo M; Wong G; Barone M; Principi M; Di Leo A; Strippoli GFM
    Can J Gastroenterol Hepatol; 2018; 2018():5437135. PubMed ID: 30320044
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New physiopathological and therapeutic approaches to diverticular disease: an update.
    Tursi A
    Expert Opin Pharmacother; 2014 May; 15(7):1005-17. PubMed ID: 24684571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Irritable bowel syndrome and colonic diverticular disease: overlapping symptoms and overlapping therapeutic approaches.
    Alamo RZ; Quigley EMM
    Curr Opin Gastroenterol; 2019 Jan; 35(1):27-33. PubMed ID: 30407258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomised clinical trial: mesalazine and/or probiotics in maintaining remission of symptomatic uncomplicated diverticular disease--a double-blind, randomised, placebo-controlled study.
    Tursi A; Brandimarte G; Elisei W; Picchio M; Forti G; Pianese G; Rodino S; D'Amico T; Sacca N; Portincasa P; Capezzuto E; Lattanzio R; Spadaccini A; Fiorella S; Polimeni F; Polimeni N; Stoppino V; Stoppino G; Giorgetti GM; Aiello F; Danese S
    Aliment Pharmacol Ther; 2013 Oct; 38(7):741-51. PubMed ID: 23957734
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diverticular disease: evolving concepts in classification, presentation, and management.
    Mosadeghi S; Bhuket T; Stollman N
    Curr Opin Gastroenterol; 2015 Jan; 31(1):50-5. PubMed ID: 25426969
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is mesalazine treatment effective in the prevention of diverticulitis? A review.
    Stefanelli G; Viscido A; Valvano M; Vernia F; Frieri G; Ashktorab H; Latella G
    Eur Rev Med Pharmacol Sci; 2020 Aug; 24(15):8164-8176. PubMed ID: 32767345
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomised clinical trial: mesalazine (Salofalk granules) for uncomplicated diverticular disease of the colon--a placebo-controlled study.
    Kruis W; Meier E; Schumacher M; Mickisch O; Greinwald R; Mueller R;
    Aliment Pharmacol Ther; 2013 Apr; 37(7):680-90. PubMed ID: 23414061
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mesalazine in treating diverticular disease of the colon.
    Tursi A
    Expert Rev Gastroenterol Hepatol; 2013 Jul; 7(5):409-12. PubMed ID: 23899280
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rationale and evidences for treatment of symptomatic uncomplicated diverticular disease.
    Cuomo R; Cargiolli M; Andreozzi P; Zito FP; Sarnelli G
    Minerva Gastroenterol Dietol; 2017 Jun; 63(2):130-142. PubMed ID: 27973463
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mesalazine for diverticular disease of the colon--a new role for an old drug.
    Tursi A
    Expert Opin Pharmacother; 2005 Jan; 6(1):69-74. PubMed ID: 15709884
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Review article: the pathophysiology and medical management of diverticulosis and diverticular disease of the colon.
    Tursi A; Papa A; Danese S
    Aliment Pharmacol Ther; 2015 Sep; 42(6):664-84. PubMed ID: 26202723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term treatment with mesalazine in patients with symptomatic uncomplicated diverticular disease.
    Gatta L; Di Mario F; Curlo M; Vaira D; Pilotto A; Lucarini P; Lera M; Enkleda K; Franzé A; Scarpignato C
    Intern Emerg Med; 2012 Apr; 7(2):133-7. PubMed ID: 21279478
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.